BSG

(Basigin)

 

  • Alias                                 (According to NCBI)

 

 
  • basigin (Ok blood group)
  • 5F7,
  • CD147,
  • EMMPRIN,
  • M6,
  • OK,
  • TCSF
  • CD147 antigen;
  • M6 leukocyte activation antigen;
  • OK blood group antigen;
  • basigin;
  • collagenase stimulatory factor;
  • extracellular matrix metalloproteinase inducer
  • Stimulates adjacent fibroblasts to produce matrix metalloproteinases (MMPS). May target monocarboxylate transporters SLC16A1, SLC16A3 and SLC16A8 to plasma membranes of retinal pigment epithelium and neural retina. Seems to be a receptor for oligomannosidic glycans. In vitro, promotes outgrowth of astrocytic processes
  • Location: 19p13.3
  • Size: 12169 bp
  • exons: 5
  • DNA sequence (Human): NC_000019

  • CGH (8q22):  Losses (%) -2.8   Gain (%)  14.0  

  • Mutations and SNPs (According to HGMD and SNP)

 

 

  • m-RNA                       (According to NCBI and CGAP)

 

  • mRNA sequence (Human): Transcript variant 1: NM_001728.2 

  •                                          Transcript variant2: NM_198589.1

  •                                          Transcript variant3 NM_198590.1

  •                                          Transcript variant4 NM_198591.1

  • Size: Transcript variant1: 2024 bp        

  •          Transcript variant2: 1676 bp

  •          Transcript varient3 1766 bp

  •          Transcript variant4 1609 bp

  • cDNA libraries: BSG

  • Size: 385 amino acids; 42200 Da
  • Subunit: Forms homooligomers in a cis-dependent manner on the plasma membrane. Forms a complex with MMP1 at the tumor cell surface. Interacts with SLC16A1 and SLC1A3; probably a BSG dimer is associated with a monocarboxylate transporter dimer. Interacts with ATP1B2, MAG and L1CAM (By similarity). Interacts with AJAP1.
  • Subcellular location: Cell membrane; Single-pass type I membrane protein (By similarity). Melanosome. Note=Colocalizes with SLC16A1 and SLC16A8. Identified by mass spectrometry in melanosome fractions from stage I to stage IV.

  • Protein domains

     

  • Pathways and interactions (According to BioCarta,PIR)

 

  • Pathway:

                        

  • Protein interactions: BSG

  • Clinical                            (According to OMIM, PubMed)